The International Network on Oesophageal Atresia (INoEA) consensus guidelines on the transition of patients with oesophageal atresia-tracheoesophageal fistula.

Michael J Rutter, Christophe Faure, Frederic Gottrand, Graham Slater, Evelyn Culnane, Vuokko Wallace, Michaela Dellenmark-Blom, Nathalie Rommel, Audrey Van Malleghem, Jessica Menzies, Marlene Soma, Usha Krishnan, Thomas A Kovesi, Anastassios C Koumbourlis, Mario Costantini, Luigi Dall'Oglio, Rene Wijnen, Mikael Bouin, David Seguy, Benjamin D Gold, Hayley Slater, Michael W Dumont

Journal: Nature reviews. Gastroenterology & hepatology 2023;20(11):735-755

PMID: 37286639

Full Text on Nature Publishing Group View on PubMed

Abstract

Oesophageal atresia-tracheoesophageal fistula (EA-TEF) is a common congenital digestive disease. Patients with EA-TEF face gastrointestinal, surgical, respiratory, otolaryngological, nutritional, psychological and quality of life issues in childhood, adolescence and adulthood. Although consensus guidelines exist for the management of gastrointestinal, nutritional, surgical and respiratory problems in childhood, a systematic approach to the care of these patients in adolescence, during transition to adulthood and in adulthood is currently lacking. The Transition Working Group of the International Network on Oesophageal Atresia (INoEA) was charged with the task of developing uniform evidence-based guidelines for the management of complications through the transition from adolescence into adulthood. Forty-two questions addressing the diagnosis, treatment and prognosis of gastrointestinal, surgical, respiratory, otolaryngological, nutritional, psychological and quality of life complications that patients with EA-TEF face during adolescence and after the transition to adulthood were formulated. A systematic literature search was performed based on which recommendations were made. All recommendations were discussed and finalized during consensus meetings, and the group members voted on each recommendation. Expert opinion was used when no randomized controlled trials were available to support the recommendation. The list of the 42 statements, all based on expert opinion, was voted on and agreed upon.

Address: Department of Paediatric Gastroenterology, Sydney Children's Hospital, Sydney, New South Wales, Australia. [email protected].; School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia. [email protected].; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Children's Center for Digestive Health Care, GI Care for Kids, LLC, Atlanta, GA, USA.; University of Lille, Reference Centre for Rare Oesophageal Diseases, CHU Lille, Lille, France.; Department of Nutrition, CHU Lille, Lille, France.; University of Montreal, CHUM Research Center (CRCHUM), Montréal, Quebec, Canada.; Department of Paediatric Surgery, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands.; Digestive Surgery and Endoscopy Unit, Bambino Gesù Children's Hospital, Rome, Italy.; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.; Division of Pulmonary & Sleep Medicine, Children's National Medical Center, Washington, DC, USA.; George Washington University School of Medicine & Health Sciences, Washington, DC, USA.; Deptartment of Paediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.; The University of Ottawa, Ottawa, Ontario, Canada.; Division of Paediatric Otolaryngology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Otolaryngology, University of Cincinnati, Cincinnati, OH, USA.; School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.; Department of Otolaryngology, Sydney Children's Hospital, Sydney, New South Wales, Australia.; Department of Nutrition and Dietetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.; Centre Hospitalier Universitaire De Lille, Lille, France.; Department of Gastroenterology, Department of Neurogastroenterology and Motility, University Hospitals Leuven, Leuven, Belgium.; Department of Neurosciences, ExpORL, Deglutology, University of Leuven, Leuven, Belgium.; Department of Paediatric Surgery, The Queen Silvia Children's hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Psychology, University of Bath, Bath, UK.; Department of Psychology, University of Eastern Finland, Joensuu, Finland.; Transition Support Service, The Royal Children's Hospital, Melbourne, Victoria, Australia.; EAT Oesophageal Atresia Global Support Groups e.V., Stuttgart, Germany.; Division of Paediatric Gastroenterology, Hepatology and Nutrition, CHU Lille, Lille, France.; Institute for Translational Research in Inflammation INFINITE, Inserm Faculté de Médecine, Université de Lille, Lille, France.; Division of Paediatric Gastroenterology & Oesophagus Development and Engineering Lab, Sainte-Justine Hospital, Montréal, Quebec, Canada.; Université de Montréal, Montréal, Quebec, Canada.

DOI: 10.1038/s41575-023-00789-w

Link outs

Subscription / membership required

Full Text Sources:

https://doi.org/10.1038/s41575-023-00789-w

MeSH Terms: Humans, Esophageal Atresia, Gastrointestinal Diseases, Quality of Life, Tracheoesophageal Fistula